ONAPGO
Generic: Apomorphine hydrochloride
- Manufacturer
- Sun Pharma
- NDC
- 27505-006
- RxCUI
- 2705789
- Route
- SUBCUTANEOUS
- ICD-10 indication
- C22.1
Affordability Check
How much will you actually pay for ONAPGO?
In 30 seconds, see every legitimate way to afford ONAPGO — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About ONAPGO
Onapgo is a prescription medication containing the active ingredient saxagliptin, which belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. By inhibiting the DPP-4 enzyme, Onapgo increases the levels of active incretin hormones, thereby increasing insulin release and decreasing glucagon levels in a glucose-dependent manner.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Apomorphine hydrochloride.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup ONAPGO →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Apomorphine hydrochloride →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Prescribing information
From the FDA-approved label for ONAPGO. Official source: DailyMed (NLM) · Label effective Dec 21, 2018
Indications and usage
Dosage and administration
Warnings
Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How ONAPGO appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
2%
131 of 5,499 plans
Most common tier
Tier 5
On 67% of covering formularies
Prior authorization required
100%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 13 | 27% |
| Tier 2 (generic) | 1 | 2% |
| Tier 4 (non-preferred brand) | 2 | 4% |
| Tier 5 (specialty) | 33 | 67% |
Step therapy: 0% of formularies
Quantity limits: 100% of formularies
Coverage breadth: 49 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
apomorphine hydrocloride
Same generic · APOMORPHINE HYDROCHLORIDE
EVEROLIMUS
Treats same condition · Everolimus
AVMAPKI FAKZYNJA CO-PACK
Treats same condition · avutometinib potassium and defactinib hydrochloride
Fludeoxyglucose F18
Treats same condition · Fludeoxyglucose F18
Portrazza
Treats same condition · necitumumab
BACLOFEN
Treats same condition · Baclofen
Pilocarpine Hydrochloride
Treats same condition · Pilocarpine Hydrochloride
TEPADINA
Treats same condition · THIOTEPA
AVGEMSI
Treats same condition · Gemcitabine
CLENPIQ
Treats same condition · SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
ONAPGO treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.